Appropriate pneumococcal vaccination in infants in Fiji

Impaired serotype-specific immune function following pneumococcal vaccination in infants with prior carriage

Paul V Licciardi, Fiona M Russell, Anne Balloch, Robert L Burton, Moon H Nahm, Gwendolyn Gilbert, Mimi LK Tang, Edward K Mulholland

2014-04-25

The impact of prior nasopharyngeal carriage on serotype-specific IgG responses following immunization with pneumococcal conjugate ..

Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses

Paul V Licciardi, Anne Balloch, Fiona M Russell, Robert L Burton, Jisheng Lin, Moon H Nahm, Edward K Mulholland, Mimi LK Tang

2012-03-01

BACKGROUND: Infections with Streptococcus pneumoniae (pneumococcus) are a cause of significant child mortality. Pneumococcal glyco..

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months

FM Russell, A Balloch, PV Licciardi, JR Carapetis, L Tikoduadua, L Waqatakirewa, YB Cheung, EK Mulholland, MLK Tang

2011-06-15

AIM: To evaluate whether the avidity of serotype-specific IgG to pneumococcal serotypes is enhanced by an increased number of dose..

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age

FM Russell, JR Carapetis, RL Burton, J Lin, PV Licciardi, A Balloch, L Tikoduadua, L Waqatakirewa, YB Cheung, MLK Tang, MH Nahm, EK Mulholland

2011-01-10

Opsonophagocytic activity (OPA) was measured following reduced infant doses of 7-valent pneumococcal conjugate vaccine (PCV-7) wit..

Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine

Anne Balloch, Paul V Licciardi, Fiona M Russell, Edward K Mulholland, Mimi LK Tang

2010-08-01

Antibodies to serotype 9V exhibit novel serogroup cross-reactivity following infant pneumococcal immunization

PV Licciardi, A Balloch, FM Russell, EK Mulholland, MLK Tang

2010-05-14

Cross-reactivity within the pneumococcal immune response was examined in this study. Significant cross-reactivity between serotype..

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial

FM Russell, JR Carapetis, A Balloch, PV Licciardi, AWJ Jenney, L Tikoduadua, L Waqatakirewa, J Pryor, J Nelson, GB Byrnes, YB Cheung, MLK Tang, EK Mulholland

2010-04-26

BACKGROUND: To evaluate the immunological impact of the 23-valent pneumococcal polysaccharide vaccine (23vPPS) at 12 months, for c..

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy

FM Russell, PV Licciardi, A Balloch, V Biaukula, L Tikoduadua, JR Carapetis, J Nelson, AWJ Jenney, L Waqatakirewa, S Colquhoun, YB Cheung, MLK Tang, EK Mulholland

2010-04-19

Fijian infants aged 6 weeks were stratified by ethnicity and randomized to receive 0, 1, 2, or 3 PCV-7 doses with or without the 2..

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine

FM Russell, A Balloch, MLK Tang, JR Carapetis, P Licciardi, J Nelson, AWJ Jenney, L Tikoduadua, L Waqatakirewa, J Pryor, GB Byrnes, YB Cheung, EK Mulholland

2009-09-18

The aim was to identify an appropriate infant pneumococcal vaccination strategy for resource poor countries. Fijian infants receiv..